(Q37958007)

25 August 2017

title

Screening of de novo tumors after liver transplantation (English)

1 reference

25 August 2017

main subject

liver transplantation

1 reference

J Ignacio Herrero

1

1 reference

25 August 2017

publication date

1 June 2012

1 reference

Journal of Gastroenterology and Hepatology

25 August 2017

published in

1 reference

25 August 2017

volume

27

1 reference

25 August 2017

issue

6

1 reference

25 August 2017

page(s)

1011-1016

1 reference

Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Risk of malignant neoplasms after liver transplantation: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Immediate listing for liver transplantation versus standard care for Child-Pugh stage B alcoholic cirrhosis: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Lifetime consumption of alcoholic beverages and risk of 13 types of cancer in men: results from a case-control study in Montreal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Analysis of causes of death in liver transplant recipients who survived more than 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

De novo malignancies after liver transplantation: a major cause of late death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Risk of colorectal carcinoma in post-liver transplant patients: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Skin cancers after liver transplantation: what to do?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Nonmelanoma skin cancer after liver transplantation. Study of risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Who is at risk for post-transplant lymphoproliferative disorders (PTLD) after liver transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Long-term probability of and mortality from de novo malignancy after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

De novo esophageal neoplasia after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Increased incidence of colorectal malignancies in renal transplant recipients: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

JC virus infection in colorectal neoplasia that develops after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Screening for skin cancer: U.S. Preventive Services Task Force recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Efficacy and safety of valganciclovir in liver-transplanted children infected with Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Persistent detection of Epstein-Barr virus DNA after pediatric liver transplantation: unclear risks and uncertain responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

The changing face of post-transplant lymphoproliferative disease in the era of molecular EBV monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Early Lung Cancer Action Project: overall design and findings from baseline screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Survival of patients with stage I lung cancer detected on CT screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Reduced lung-cancer mortality with low-dose computed tomographic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Should we screen for colorectal cancer in liver transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Clinical practice. Screening for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Cost-effectiveness of colorectal cancer screening in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Diagnosis and management of primary sclerosing cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Screening for prostate cancer in U.S. men ACPM position statement on preventive practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Early results of bladder-cancer screening in a high-risk population of heavy smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Screening for bladder cancer: U.S. Preventive Services Task Force recommendation statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: The effect of smoking withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Liver Transplant Recipients Older Than 60 Years Have Lower Survival and Higher Incidence of Malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

Is the Effectiveness of Colonoscopy "Good Enough" for Population-Based Screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06981.X

10.1111/J.1440-1746.2011.06981.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference